SEC Form 4 · accession 0001209191-17-048398
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew E. Singer
Officer — EVP & CFO
Period of report
Aug 9, 2017
Accepted (ET)
Aug 10, 2017 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Commons Stock, par value $0.0001F1 | Aug 9, 2017 | M | 1,682 | — | A | 44,668 | D | |
| Commons Stock, par value $0.0001F1 | Aug 9, 2017 | M | 778 | — | A | 45,446 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 9, 2017 | M | 1,682 | D | — | — | Common Stock | 1,682 | 30,274 | D |
| Restricted Stock UnitsF1,F3 | — | Aug 9, 2017 | M | 778 | D | — | — | Common Stock | 778 | 13,992 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
- F2This award, granted on February 9, 2016, pursuant to the Company's 2013 Stock Incentive plan, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
- F3This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.